0000950170-24-046178.txt : 20240419 0000950170-24-046178.hdr.sgml : 20240419 20240419192706 ACCESSION NUMBER: 0000950170-24-046178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240418 FILED AS OF DATE: 20240419 DATE AS OF CHANGE: 20240419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Timothy Eugene CENTRAL INDEX KEY: 0001707000 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 24859262 MAIL ADDRESS: STREET 1: 800 BOYLSTON ST., SUITE 3310 STREET 2: PRUDENTIAL TOWER C/O AJU IB INVESTMENT CITY: BOSTON STATE: MA ZIP: 02199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml 4 X0508 4 2024-04-18 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001707000 Sullivan Timothy Eugene C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 false true false false Chief Financial Officer false Common Stock 2024-04-18 4 G false 14164 0.00 D 79174 D Common Stock 2024-04-18 4 G false 14164 0.00 A 70396 I Indirect Owner (The Timothy E Sullivan Irrevocable Trust of 2023) On April 18, 2024, the reporting person transferred 14,164 shares to The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein. /s/ David Watson, attorney-in-fact for Timothy Sullivan 2024-04-19